Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC4334 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Head and Neck Cancer |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Head and Neck Cancer Peripheral Blood Mononuclear Cells are immune cells isolated from the peripheral blood of patients with head and neck squamous cell carcinoma (HNSCC). These cells primarily consist of lymphocytes (T cells, B cells, and NK cells) and monocytes. Morphologically, PBMCs are typically small, round cells. PBMCs play a key role in antitumor immune responses T cells mediate cellular immunity, B cells produce antibodies, and NK cells execute innate cytotoxicity, whereas monocytes differentiate into tumor-associated macrophages (TAMs) that modulate the tumor microenvironment. In HNSCC, PBMCs often exhibit immune dysfunction, such as T-cell exhaustion or increased secretion of immunosuppressive cytokine, contributing to immune evasion and disease progression.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Head and Neck Cancer Peripheral Blood Mononuclear Cells have valuable applications in biomedical research. As a key component of the immune system, these cells can be used to construct in vitro models to simulate the tumor microenvironment by isolating immune cell populations such as lymphocytes and monocytes from the patient’s peripheral blood. In the field of drug research and development, they are used to evaluate the effiectiveness and safety of immunotherapeutic agents.